New Market Report Now Available: Bone Disorders - Pipeline Review, H2 2013

Aug. 6, 2013 - PRLog -- Global Markets Direct's, 'Bone Disorders - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Bone Disorders, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Bone Disorders. Bone Disorders - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

 * A snapshot of the global therapeutic scenario for Bone Disorders.
 * A review of the Bone Disorders products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
 * Coverage of products based on various stages of development ranging from discovery till registration stages.
 * A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
 * Coverage of the Bone Disorders pipeline on the basis of route of administration and molecule type.
 * Key discontinued pipeline projects.
 * Latest news and deals relating to the products.

------------------------------------------------------------
Full Report Details at
 - http://www.fastmr.com/prod/666870_bone_disorders_pipeline...
------------------------------------------------------------

Reasons to buy

 * Identify and understand important and diverse types of therapeutics under development for Bone Disorders.
 * Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
 * Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
 * Devise corrective measures for pipeline projects by understanding Bone Disorders pipeline depth and focus of Indication therapeutics.
 * Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
 * Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.


Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Bone Disorders Overview
Therapeutics Development
An Overview of Pipeline Products for Bone Disorders
Bone Disorders Therapeutics under Development by Companies
Bone Disorders Therapeutics under Investigation by Universities/Institutes
Early Clinical Stage Products
Comparative Analysis
Discovery and Pre-Clinical Stage Products
Comparative Analysis
Bone Disorders Therapeutics - Products under Development by Companies
Bone Disorders Therapeutics - Products under Investigation by Universities/Institutes
Companies Involved in Bone Disorders Therapeutics Development
Sanofi-Aventis
Ablynx
BioMarin Pharmaceutical Inc.
Bayer AG
Enzo Biochem, Inc.
Medivir AB
Osteologix, Inc.
Alethia Biotherapeutics Inc.
Siena Biotech S.p.A.
Pharis Biotec GmbH
Prosensa Therapeutics B.V.
Bone Disorders - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
ALX-0141 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
MIV-710 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
MIV-711 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Enzo-D58 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
WX-04554 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
BMN-111 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
R-111 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Tsp50 Inhibitors - Drug Profile
Product Description
Mechanism of Action
R&D Progress
JP4-039 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Monoclonal Antibody For Bone Diseases - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Drug For Bone Diseases and Osteoarthritis - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Drug For Autoimmune Bone Diseases - Drug Profile
Product Description
Mechanism of Action
R&D Progress
APX-008 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Recombinant BMP-2 Biosimilar - Drug Profile
Product Description
Mechanism of Action
R&D Progress
P-881 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
VS-110 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
poncirin - Drug Profile
Product Description
Mechanism of Action
R&D Progress
ZK-191784 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
ST-03 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Glucocorticoid-Induced Leucine Zipper - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Matrix Metalloprotease And Pro-Inflammatory Cytokine Inhibitors - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Allogeneic Stem Cells - Drug Profile

Full Table of Contents is available at:
-- http://www.fastmr.com/catalog/product.aspx?productid=6668...

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information.  View more research from Global Markets Direct at http://www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.